The Molecular Biology Society of Japan

The 42nd Annual Meeting of the Molecular Biology Society of Japan

The 42nd Annual Meeting of the Molecular Biology Society of Japan

Dec 3, 2019 - Dec 6, 2019
Fukuoka International Congress Center・Fukuoka sunpalace hotel & hall・Marine Messe Fukuoka

[1P-0591] Application of the novel CRISPR-Cas3 technology for low immune rejection iPS cell therapy and Duchenne muscular dystrophy gene therapy

〇Yuya Okuzaki1, Yuto Kita1, Gee Peter1, Noriko Sasakawa1, Huaigeng Xu1, Hiroyuki Morisaka3, Kazuto Yoshimi2, Junji Takeda3, Tomoji Mashimo2, Akitsu Hotta1 (1.CiRA, Kyoto Univ.,, 2.IEXAS, Grad. Sch. of Med., Osaka Univ.,, 3.RIMD, Osaka Univ.,)

genome editing, CRISPR-Cas, iPSC, immune rejection, Duchenne muscular dystrophy

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password